Literature DB >> 25754470

The role of uncertainty regarding the results of screening immunoassays in blood establishments.

Paulo Pereira1, James O Westgard2, Pedro Encarnação3, Jerard Seghatchian4, Gracinda de Sousa5.   

Abstract

The risk of uncertain results in infectious agents' tests is recognized in blood establishments, being particularly evident during the blood donor selection. The current risk-based approaches require risk assessment and "risk-based thinking". Accordingly, the blood establishment should consider the effect of uncertainty in all the technical decisions taken in a screening laboratory. Since the post-transfusion safety is one of the blood establishments' goals, the risk of post-transfusion infection should be evaluated and actions taken to decrease the chance of blood donations validation use false negative results. This article reviews and discusses the sources of uncertainty of infectious agents' reported results in blood establishments. It describes a set of sources of uncertainty that should be considered in screening immunoassay's decisions. The infectious agents' uncertainty concern is critical for reporting reliable results.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Blood donor selection; Blood establishments; Infectious agents; Post-transfusion safety; Risk assessment; Screening immunoassay

Mesh:

Year:  2015        PMID: 25754470     DOI: 10.1016/j.transci.2015.02.015

Source DB:  PubMed          Journal:  Transfus Apher Sci        ISSN: 1473-0502            Impact factor:   1.764


  2 in total

1.  Impact of grey zone sample testing by enzyme-linked immunosorbent assay in enhancing blood safety: Experience at a tertiary care hospital in North India.

Authors:  Archana Solanki; Abhay Singh; Rajendra Chaudhary
Journal:  Asian J Transfus Sci       Date:  2016 Jan-Jun

2.  The impact of grey zones on the accuracy of agreement measures for ordinal tables.

Authors:  Quoc Duyet Tran; Anil Dolgun; Haydar Demirhan
Journal:  BMC Med Res Methodol       Date:  2021-04-14       Impact factor: 4.615

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.